Balancing Risk and Efficiency in Drug Development for Rare and Challenging Tumors: A New Paradigm for Glioma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Balancing Risk and Efficiency in Drug Development for Rare and Challenging Tumors: A New Paradigm for Glioma
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
American Society of Clinical Oncology (ASCO)
Online
2022-02-25
DOI
10.1200/jco.21.02166
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [64Cu]Cu-NOTA-anti-CD8-Positron Emission Tomography
- (2021) Veronica L Nagle et al. CLINICAL CANCER RESEARCH
- Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
- (2021) Tina Cascone et al. NATURE MEDICINE
- Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial
- (2021) Ingo K. Mellinghoff et al. CLINICAL CANCER RESEARCH
- GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma.
- (2021) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- MRI biomarkers in neuro-oncology
- (2021) Marion Smits Nature Reviews Neurology
- The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
- (2021) David N Louis et al. NEURO-ONCOLOGY
- Practical Considerations and Recommendations for Master Protocol Framework: Basket, Umbrella and Platform Trials
- (2021) Chengxing Lu et al. Therapeutic Innovation & Regulatory Science
- The Use of External Controls in FDA Regulatory Decision Making
- (2021) Mahta Jahanshahi et al. Therapeutic Innovation & Regulatory Science
- Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity Trial
- (2021) Francesco Schettini et al. Frontiers in Oncology
- Leveraging external data in the design and analysis of clinical trials in neuro-oncology
- (2021) Rifaquat Rahman et al. LANCET ONCOLOGY
- Multiparametric MR-PET Imaging Predicts Pharmacokinetics and Clinical Response to GDC-0084 in Patients with Recurrent High-Grade Glioma
- (2020) Benjamin M. Ellingson et al. CLINICAL CANCER RESEARCH
- MDNA55 survival in recurrent glioblastoma (rGBM) patients expressing the interleukin-4 receptor (IL4R) as compared to a matched synthetic control.
- (2020) John H. Sampson et al. JOURNAL OF CLINICAL ONCOLOGY
- Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions
- (2020) Patrick Y Wen et al. NEURO-ONCOLOGY
- Volumetric Analysis of IDH-Mutant Lower-Grade Glioma: A Natural History Study of Tumor Growth Rates Before and After Treatment
- (2020) Raymond Y Huang et al. NEURO-ONCOLOGY
- Synthetic and External Controls in Clinical Trials – A Primer for Researchers
- (2020) Kristian Thorlund et al. Clinical Epidemiology
- Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma
- (2020) David A. Reardon et al. JAMA Oncology
- Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase 2 Trial
- (2020) Ravindra Uppaluri et al. CLINICAL CANCER RESEARCH
- Ivosidenib in Isocitrate Dehydrogenase 1–Mutated Advanced Glioma
- (2020) Ingo K. Mellinghoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 0/microdosing approaches: time for mainstream application in drug development?
- (2020) Tal Burt et al. NATURE REVIEWS DRUG DISCOVERY
- Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma
- (2020) Timothy F. Cloughesy et al. JAMA Oncology
- Challenges to curing primary brain tumours
- (2019) Kenneth Aldape et al. Nature Reviews Clinical Oncology
- Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
- (2019) Timothy F. Cloughesy et al. NATURE MEDICINE
- Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid
- (2019) Alexandra M. Miller et al. NATURE
- Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial
- (2019) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB)
- (2019) Ingrid A. Mayer et al. CLINICAL CANCER RESEARCH
- Design and Evaluation of an External Control Arm Using Prior Clinical Trials and Real-World Data
- (2019) Steffen Ventz et al. CLINICAL CANCER RESEARCH
- Molecular and Clinical Activity of CDX-3379, an Anti-ErbB3 Monoclonal Antibody, in Head and Neck Squamous Cell Carcinoma
- (2019) Umamaheswar Duvvuri et al. CLINICAL CANCER RESEARCH
- To randomize, or not to randomize, that is the question: using data from prior clinical trials to guide future designs
- (2019) Alyssa M Vanderbeek et al. NEURO-ONCOLOGY
- Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant
- (2019) Jennifer K. Litton et al. JOURNAL OF CLINICAL ONCOLOGY
- Adaptive platform trials: definition, design, conduct and reporting considerations
- (2019) NATURE REVIEWS DRUG DISCOVERY
- First-in-human imaging with 89Zr-Df-IAB22M2C anti-CD8 minibody in patients with solid malignancies: preliminary pharmacokinetics, biodistribution, and lesion targeting
- (2019) Neeta Pandit-Taskar et al. JOURNAL OF NUCLEAR MEDICINE
- ACTR-66. A PHASE 1, OPEN-LABEL, PERIOPERATIVE STUDY OF IVOSIDENIB (AG-120) AND VORASIDENIB (AG-881) IN RECURRENT IDH1 MUTANT, LOW-GRADE GLIOMA: UPDATED RESULTS
- (2019) Ingo Mellinghoff et al. NEURO-ONCOLOGY
- Window of opportunity clinical trial designs to study cancer metabolism
- (2019) Francesca Aroldi et al. BRITISH JOURNAL OF CANCER
- Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)
- (2018) J -P Machiels et al. ANNALS OF ONCOLOGY
- Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial
- (2018) K. Kalinsky et al. Clinical & Translational Oncology
- The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?
- (2018) Alyssa M Vanderbeek et al. NEURO-ONCOLOGY
- Beyond the Blood:Brain Barrier: The Importance of Central Nervous System (CNS) Pharmacokinetics for the Treatment of CNS Tumors, Including Diffuse Intrinsic Pontine Glioma
- (2018) Katherine Elizabeth Warren Frontiers in Oncology
- T cell receptor richness in peripheral blood increases after cetuximab therapy and correlates with therapeutic response
- (2018) Benjamin A. Kansy et al. OncoImmunology
- Window Studies in Squamous Cell Carcinoma of the Head and Neck: Values and Limits
- (2018) Dan P. Zandberg et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Drug development for glioma: are we repeating the same mistakes?
- (2018) Roger Stupp LANCET ONCOLOGY
- Brain Tumor Imaging
- (2017) Kevin M. Brindle et al. JOURNAL OF CLINICAL ONCOLOGY
- Diffuse Infiltrating Oligodendroglioma and Astrocytoma
- (2017) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- Response Assessment in Neuro-Oncology Clinical Trials
- (2017) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Adult Glioblastoma
- (2017) Brian M. Alexander et al. JOURNAL OF CLINICAL ONCOLOGY
- Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
- (2017) Michael Weller et al. LANCET ONCOLOGY
- Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma
- (2017) Wilson X Mai et al. NATURE MEDICINE
- Lomustine and Bevacizumab in Progressive Glioblastoma
- (2017) Wolfgang Wick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Window of opportunity studies: Do they fulfil our expectations?
- (2016) Sandra Schmitz et al. CANCER TREATMENT REVIEWS
- Presurgical window of opportunity trial design as a platform for testing anticancer drugs: Pros, cons and a focus on breast cancer
- (2016) Marcello Maugeri-Saccà et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid
- (2016) Elena I. Pentsova et al. JOURNAL OF CLINICAL ONCOLOGY
- Designs of preoperative biomarkers trials in oncology: a systemic review of the literature
- (2015) M. Marous et al. ANNALS OF ONCOLOGY
- Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord
- (2015) Yuxuan Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma
- (2015) Leticia De Mattos-Arruda et al. Nature Communications
- Erlotinib, Erlotinib-Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer
- (2014) N. D. Gross et al. CLINICAL CANCER RESEARCH
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- (2014) Olivier L. Chinot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck
- (2013) S. Schmitz et al. ANNALS OF ONCOLOGY
- Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma
- (2013) Tracy T. Batchelor et al. JOURNAL OF CLINICAL ONCOLOGY
- Adaptive Clinical Trials
- (2013) Jeff Maca et al. Therapeutic Innovation & Regulatory Science
- Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial
- (2012) Bernardo Bonanni et al. JOURNAL OF CLINICAL ONCOLOGY
- Cracking Open Window of Opportunity Trials
- (2012) Kevin Kalinsky et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 2 trial design in neuro-oncology revisited: a report from the RANO group
- (2012) Evanthia Galanis et al. LANCET ONCOLOGY
- Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors
- (2012) Igor Vivanco et al. Cancer Discovery
- Window-of-opportunity trials to evaluate clinical activity of new molecular entities in oncology
- (2011) B. Glimelius et al. ANNALS OF ONCOLOGY
- A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer
- (2011) Suleiman Massarweh et al. BREAST CANCER RESEARCH AND TREATMENT
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib--A Phase II Trial
- (2011) M. E. Hegi et al. MOLECULAR CANCER THERAPEUTICS
- Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma
- (2010) Roger Stupp et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma
- (2010) Wolfgang Wick et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
- (2010) John H. Sampson et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 0 Clinical Trials: An Answer to Drug Development Stagnation?
- (2009) Patricia M. LoRusso JOURNAL OF CLINICAL ONCOLOGY
- Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies
- (2009) Shivaani Kummar et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Short Preoperative Treatment With Erlotinib Inhibits Tumor Cell Proliferation in Hormone Receptor–Positive Breast Cancers
- (2008) Marta Guix et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now